Breaks Categories: News

MondayOct 25, 2021 12:32 pm

CannabisNewsBreaks – CWCBExpo Names CannabisNewsWire as Official Newswire for NYC’s CWCBExpo

Cannabis World Congress & Business Exposition (“CWCBExpo”) announced that it has again partnered with CannabisNewsWire (“CNW”), a specialized communications platform for the cannabis sector and one of the more than 50 brands that make up InvestorBrandNetwork (“IBN”). CNW is also a sapphire sponsor of the event, which will be held Nov. 4–6, 2021, at the Javits Convention Center in New York City. This year’s NYC CWCBExpo agenda features more than 50 speakers and thought leaders who will provide vital insight and information regarding the industry. Keynote speakers, panel discussions and various sessions will cover pertinent, relevant topics chosen to support…

Continue Reading

MondayOct 25, 2021 11:28 am

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Opens Pathway to Dry Flower Export Through Receipt of GACP Certification

Flora Growth Corp. (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced its receipt of the Good Agricultural and Collection Practices (“GACP”) certification by the Control Union Medical Cannabis Standard (“CUMCS”). According to the update, paired with the recent Colombian law change, Flora can now export its high-quality dry flower to international GMP active pharmaceutical ingredient (“API”) producers or to markets where flower can be imported. “In advance of this milestone, our team has signed several LOIs for the sale and distribution of dry flower and derivative products to several international jurisdictions, including…

Continue Reading

ThursdayOct 21, 2021 11:10 am

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Unveils New Cannabis Wellness Brand

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, and its Flora Lab division is launching Munzhi, a new cannabis wellness brand. The mass market brand will initially include 12 products, all certified by INVIMA, the Colombian branch of government that is equivalent to the United Stated Food and Drug Administration. The products will be distributed by five Colombian distributors, including Herson, Mintlab, Unidrogas, Roma and Axa, and will be available in an estimated 800 distribution points. Flora Lab is FLGC’s manufacturing and R&D division; Flora Lab is focused on development of pharmaceuticals,…

Continue Reading

WednesdayOct 20, 2021 11:08 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Study Reveals Effectiveness of Proprietary Drug-Development Tech

Lexaria Bioscience (NASDAQ: LEXX), developers of the revolutionary DehydraTECH(TM) drug-delivery technology, has released study results focused on THC-A21-1, a THC oral format. According to the announcement, the study showed that Lexaria’s DehydraTECH THC solution delivers THC levels to blood plasma an estimated three times faster than standard MCT-based THC. Based on study results, it took only 15 minutes using oral ingestion of the substance to reach THC levels comparable to those reached in 45 minutes using "coconut-oil" formulations. As the THC left the system at the six-hour mark, levels were comparable and demonstrated the fast-on, fast-off performance. The DehydraTECH results are timely…

Continue Reading

WednesdayOct 20, 2021 10:36 am

CannabisNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Granted Approval to Evaluate Sensory Factors in Product-Development Trials

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) has received an amendment to a cannabis research license it had previously been granted by Health Canada. The amendment allows the company to include sensory evaluations of cannabis beverages in an upcoming product development trial. According to the announcement, the company will be able to  conduct onsite human assessments of the taste, smell, feel and visual appeal of products the company is developing, a move that BevCanna says will provide significant advantages for its white-label clients as well as in-house brands because the new-product trial capabilities are unique in the Canadian cannabis beverage…

Continue Reading

TuesdayOct 19, 2021 12:43 pm

CannabisNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Enters Functional CBD Water Space in the Golden State

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), the country’s largest independent alkaline water company and The Clean Beverage(R) company, has announced that it will begin sales in California of its six new A88CDB(TM) functional waters after passage of Assembly Bill 45 in the Golden State. The six natural, functional A88CBD waters—Relax, Refresh, Resistance, Relief, Reenergize, and Rest—will be sold through A88 Infused Products Inc., a wholly-owned subsidiary of the company. The product’s innovative packaging utilizes a pressurized Vessl(R) closure that contains 25mg of CBD and other functional vitamins and ingredients, which freshly infuse at 110psi into the alkaline water…

Continue Reading

MondayOct 18, 2021 11:05 am

CannabisNewsBreaks – ‘Queen of Green’ Dr. Kara Coe Provides Business Update Relative to Virginia’s Momentous Policy Shift

The state of Virginia officially legalized the consumption and possession of recreational marijuana in July 2021, a momentous policy shift that followed the state’s opening of its medical marijuana market a little over a year ago. Forensic-psychologist-turned-entrepreneur Dr. Kara Coe, popularly known within professional cannabis circles as the “Queen of Green,” has been on the forefront of the Virginia cannabis movement, most recently through the launch of her diverse cannabis-focused business portfolio. Today, Dr. Coe provided an update on her business endeavors relative to Virginia’s recent recreational cannabis legalization. “Women nurture others by nature, so even though this is a…

Continue Reading

ThursdayOct 14, 2021 1:16 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Completion of BayMedica Acquisition

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing and clinical development of rare cannabinoids, has finalized the acquisition of BayMedica Inc., a private company based in the U.S. specializing in the manufacturing and commercialization of rare cannabinoids for the health and wellness sector. INM had announced the acquisition earlier. According to the announcement, the acquisition provides capabilities and resources to accelerate InMed’s commercial initiatives, including the development and unveiling of several new cannabinoids products in the consumer health and wellness sector. The combined technologies include synthetic biology, chemical synthesis and IntegraSyn(TM), a patented enzymatic biotransformation. The company noted that, with…

Continue Reading

ThursdayOct 14, 2021 11:11 am

CannabisNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) Enters Agreement to Bring Averi’s Cannabis-Infused Concepts to Life

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), an emerging leader in innovative health and wellness beverages and products, has announced its entry into an agreement to manufacture and distribute white-label cannabis beverages for Averi Health Products. A new adult alternative beverage company founded by Terry Donnelly, creator and former CEO of the award-winning Hill Street Beverage Co., Averi will launch a portfolio of cannabis-infused beverages into the Canadian market. Under the agreement, Averi will leverage BevCanna’s extensive experience in producing beverages at scale as well as its sales license partnership for distribution to Canadian provincial buying groups. “Averi is…

Continue Reading

WednesdayOct 13, 2021 2:13 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Impressive Findings of Oral THC Absorption Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that its recent oral tetrahydrocannabinol (“THC”) absorption study THC-A21-1 revealed that DehydraTECH(TM)-THC delivered via oral ingestion required only 15 minutes to deliver THC levels in blood plasma comparable to levels achieved at 45 minutes with concentration-matched controls. According to the update, DehydraTECH-THC delivered more THC into the bloodstream during the study than the industry standard medium chain triglyceride (“MCT” or “coconut oil”) based control formulation from the two-minute mark onwards, then dropped rapidly to the same level as the MCT control by the six-hour mark. “The…

Continue Reading